Precious Metal Recovery Solutions for the Pharmaceutical Industry
At Re Sustainability Reldan Refining we help pharmaceutical and fine-chemical manufacturers recover valuable precious and platinum-group metals (PGMs) from spent catalysts, residues, and R&D materials. Our specialised processes convert metal-bearing waste streams into reclaimed value, ensuring full traceability, compliance, and sustainability.
We serve the API, bulk drug, and intermediate manufacturing ecosystem, from pilot R&D to large-scale plants, helping you recover precious metals such as Palladium, Platinum, Rhodium, Ruthenium, from complex matrices like catalysts, solvents, and process residues.
Our expertise covers a wide range of pharma-specific materials
- Spent hydrogenation catalysts
- Homogeneous catalyst residues and organometallic compounds used in fine-chemical synthesis
- Solvent and aqueous waste streams containing dissolved precious metals
- Laboratory and pilot-scale rejects and analytical residues
- Filter media, carbon, and sludges containing PGMs or precious metals
Using a combination of hydrometallurgical and pyrometallurgical processes, we process metals with high yield and purity. Each batch is treated under controlled, audited conditions with full chain-of-custody documentation, ISO-certified assay reports, and environmentally responsible handling of residues.
We offer flexible and transparent engagement models, designed to align with each client’s operational needs and long-term partnership goals.. Our process ensures maximum recovery, full transparency, and complete confidentiality for all pharma and R&D clients.
In a sector where quality, compliance, and trust define every decision, our mission is simple: to help the pharmaceutical industry close the loop on precious metals responsibly and profitably.
For more information or to schedule a confidential material assessment, contact us at